Clinipace Selects TransPerfect’s Trial Interactive E-Feasibility and eTMF Solutions to Support Future Studies

March 18, 2019 Off By BusinessWire

NEW YORK–(BUSINESS WIRE)–TransPerfect
Life Sciences, a leading provider of technologies and services to
support clinical trials and product development for the
biopharmaceutical industry, today announced that Clinipace has selected
TransPerfect’s Trial
Interactive E-Feasibility and eTMF solutions as part of their
ongoing initiative to further cultivate a flexible and responsive
infrastructure to support clinical research.

Clinipace is a global, full-service contract research organization (CRO)
providing personalized services and solutions, local regulatory
expertise, and therapeutic leadership across major therapeutic areas
that include oncology, gastroenterology, nephrology, and urology.
Investments in innovative technologies enable Clinipace to provide
industry-leading tools to staff, site personnel, and clients with
maximum transparency and visibility.

The Trial Interactive e-clinical platform was designed by clinical
professionals, for clinical professionals. It is used by pharmaceutical,
biotechnology, and CRO companies to streamline product development life
cycles in a secure, 21 CFR Part 11-compliant environment. By offering a
fully integrated suite of solutions, Trial Interactive improves speed
and quality across site identification and selection, personnel
training, study start-up and site activation, eTMF management, and
closeout. The Trial Interactive platform delivers nuanced, clinical
research-focused products that simplify tasks, oversight, compliance,
and audits/inspections.

“We reviewed many solutions, and Trial Interactive offered the intuitive
interface, transparency, hosting, support, and validation that was
essential to our decision,” said Michael Townley, CIO, Clinipace. “The
additional willingness to work with our other vendors and integration
partners made Trial Interactive an obvious choice.”

“We are proud to have been selected by Clinipace to add our
E-Feasibility and eTMF solutions to their technology stack,” said Phil
Shawe, President and CEO of TransPerfect. “The studies they conduct are
essential to bringing important treatments to market and improving
patient lives.”

About Trial Interactive
TransPerfect’s Trial Interactive
solution provides a collaborative, web-based platform for clinical
development that enables sponsors, CROs, IRBs, and other vendors to
maintain and update clinical trial documentation in a secure online
environment, adhering to global regulatory requirements. With fully
searchable solutions, Trial Interactive streamlines study timelines and
reduces the administrative burdens of global clinical trials. As part of
TransPerfect’s Life Sciences division, Trial Interactive is dedicated to
working with clients on a global, collaborative level, supporting a wide
range of requirements including e-feasibility, study start-up, eTMF
review/reconciliation, mobile applications, learning management and
document management systems, investigator portals, pharmacovigilance and
safety management, and endpoint adjudication. For more information on
Trial Interactive, please contact [email protected]
or +1 212.400.8848, or visit www.trialinteractive.com.

About TransPerfect
TransPerfect is the world’s largest
provider of language services and technology solutions for global
business. From offices in over 90 cities on six continents, TransPerfect
offers a full range of services in 170+ languages to clients worldwide.
More than 4,000 global organizations employ TransPerfect’s GlobalLink®
Product Suite to simplify management of multilingual content. With an
unparalleled commitment to quality and client service, TransPerfect is
fully ISO 9001 and ISO 17100 certified. TransPerfect has global
headquarters in New York, with regional headquarters in London and Hong
Kong. For more information, please visit our website at www.transperfect.com.

About Clinipace
At Clinipace,
a global, full-service contract research organization (CRO), our
approach to clinical research is personal. We deliver a level of
collaboration and flexibility not possible in a traditional CRO
environment. Our personalized services and solutions, local regulatory
expertise and therapeutic leadership are designed to face the most
difficult industry challenges across all major therapeutic areas
including oncology, gastroenterology, nephrology and urology, rare
disease, and women’s health. We strive to improve the way clinical
research is performed and impact the future of health care using the
most advanced technology and a CHALLENGE ACCEPTED approach.